Compare Amphastar Pharmaceuticals Inc (AMPH) vs Amazon.com Inc (AMZN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Amphastar Pharmaceuticals Inc vs Amazon.com Inc — how do they compare? Amphastar Pharmaceuticals Inc trades at $20.39 (market cap $868.62M), while Amazon.com Inc trades at $273.55 (market cap $2.94T). The key difference: Amazon.com Inc is far larger — about 3384.7× Amphastar Pharmaceuticals Inc's market cap, and Amazon.com Inc is trading nearer its 52-week high, Amphastar Pharmaceuticals Inc nearer its low. Which is the better fit depends on your goals.
| AMPH | AMZN | |
|---|---|---|
Market Cap | $868.62M | $2.94T |
Sector | Health | Consumer Cyclical |
52-Week High | $30.81 | $284.02 |
52-Week Low | $16.87 | $198.79 |
Enterprise Value | $1.27B | $3.04T |
Volume | — | 3,931,282 |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
AMPH trades at $20.78, up 4.9% today, with a bullish technical signal supported by moving averages. The stock shows mixed earnings performance with Q2 2026 beating estimates but Q1 and Q4 2025 missing. Fundamentals remain solid with a 10.76% net margin and reasonable valuation at 12.02 P/E. Recent news highlights Q2 2026 results and strategic shift toward proprietary drugs.
Outlook is cautiously optimistic with growth supported by new product launches, though regulatory risks and earnings volatility pose challenges. Analyst sentiment is mixed with 25% buy ratings but majority hold recommendations. The stock offers value but requires monitoring of FDA developments and earnings consistency.
Amazon (AMZN) trades at $278.09, up 1.32% with strong technical momentum and bullish moving averages. The company demonstrates robust fundamentals with revenue growth from $638B in 2024 to $716.9B in 2025 and net income surging to $77.7B. Recent earnings show beats in Q1 and Q2 2026, while analyst sentiment remains overwhelmingly positive with 89% buy ratings and a $333.86 consensus price target.
Amazon's outlook remains favorable with accelerating AI investments and AWS growth driving future cash flows. Key risks include aggressive capital expenditure plans ($216.8B investing outflow projected for 2026) and intensifying competition in e-commerce and cloud services. The stock presents growth potential but requires monitoring of execution on massive infrastructure investments.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Amphastar Pharmaceuticals Inc
Amphastar is a specialty pharmaceutical company that develops and markets injectable, intranasal, and inhalation products. Its portfolio includes both complex generic drugs and proprietary delivery systems.
Read more on AMPH →About Amazon.com Inc
Amazon.com, Inc. is an online retailer that offers a wide range of products. The Company products include books, music, computers, electronics and numerous other products. Amazon offers personalized shopping services, Web-based credit card payment, and direct shipping to customers. Amazon also operates a cloud platform offering services globally.
Read more on AMZN →
